JPRN-UMIN000048975
Not yet recruiting
未知
Observational Study on Novel Biomarkers for Prediction of Pneumonia in the Elderly - Observational Study for Prediction of Pneumonia in the Elderly
agasaki University Hospital Department of Respiratory Medicine0 sites160 target enrollmentSeptember 22, 2022
ConditionsPneumonia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pneumonia
- Sponsor
- agasaki University Hospital Department of Respiratory Medicine
- Enrollment
- 160
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Those who have developed pneumonia at the time of obtaining consent 2\.Those who do not give consent for blood or urine collection 3\.Those who have decided to move to a new location during the approximately 2\-year observation period. 4\.Those with malignant diseases, whose prognosis is considered to be within about 2 years. 5\.Other patients who are deemed inappropriate as research subjects by the investigator or others.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000010140Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences216
Recruiting
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseJPRN-UMIN000014093Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences512
Completed
Not Applicable
Study for new biomarker development in the prediction of renal anemia progression in chronic kidney diseaseJPRN-UMIN000008699Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences90
Recruiting
Not Applicable
Prospective observational study of biomarkers to predict efficacy after Nivolumab in patients with previously treated advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000020823Gunma University30
Unknown
Not Applicable
Prospective observational study of biomarkers to predict efficacy after Pembrolizumab in patients with PD-L1 positive advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000026793Gunma University50